SourcingAI
Try for free
Powered by Made-in-China.com
250ml Plastic Bottle Sodium Chloride Injection 0.9%-Huaren Pharmaceutical
US$0.14-0.22
1,000 bottle
Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Application

Other

Usage Mode

Intravenous Drip

Suitable for

Elderly, Children, Adult

State

Liquid

Shape

Liquid

Type

Inorganic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

H45020976

Chemical Name

Sodium Chloride

Chemical Structural Formula

Nacl

Molecular Formula

Nacl

Molecular Weight

58.44

Packaging

Polypropylene Infusion Bottle

Transport Package

Carton

Specification

250mL

Trademark

Huaren

Origin

Qingdao, Shandong, China

Production Capacity

10000000

Key features

Comprehensive Indications: Treats dehydration, diabetic coma, alkalosis, and used for wound rinsing or abortion induction.
Strict Quality Standards: Manufactured according to Pharmacopoeia of the People's Republic of China (2020, Volume II).
Flexible Customization: Offers full, minor, and flexible customization from samples or designs.
OEM and ODM Services: Manufacturer provides both OEM and ODM services with 100 R&D engineers.
100% Product Inspection: All finished products undergo visual and functional inspection before shipment.
Long-Term Experience: 25 years of export experience with 12 production lines and 559 employees.
Fast Lead Time: Off-season delivery within 15 workdays; peak season within one month.
Traceable Raw Materials: Full traceability system implemented for all raw materials used in production.

Company profile

Huaren Pharmaceutical Co., Ltd.
Importers and ExportersHigh Repeat Buyers ChoiceYears of Export ExperienceExperienced Team
CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 25 Years CertifiedNearest Port: Qingdao PortAverage Response Time: >24h

AI-Powered supplier vetting

SummaryThe supplier is a limited company founded in 1998, with 559 employees and a 54,736.0 m² manufacturing plant. It operates across pharmaceuticals, APIs, medical devices, medical services, medical supplies, and related production and trading activities. Evidence confirms OEM services for well-known brands, SDK availability, valid manufacturing contracts, quality assurance, raw-material traceability, and documented corrective-action and complaint-handling procedures. The supplier has an effective import/export license and reports overseas service coverage in Russia, but lacks in-stock capacity, overseas warehouses, overseas showrooms, overseas agents or branches, and offline trade-show participation. Financial information is insufficient for a credibility assessment, and no specific customer cases or formal certifications are provided.
Supplier typeThe supplier is identified as a limited company and a combined business, founded in 1998, with activities spanning pharmaceutical and health products, medical devices, manufacturing, processing, and sales. It is not identified as an offshore company and is not part of a larger company group.
After-Sales capabilityThe supplier has documented corrective and preventive action procedures, complaint-handling procedures with records, quality assurance, and raw-material traceability. It can provide overseas services in Russia, but has no overseas agents or branches, overseas warehouse, or overseas showroom, limiting local and inventory-based support.
R&D capabilityThe supplier explicitly reports R&D capability and SDK availability, and describes a strategy involving independent research and collaborative innovation. Its company profile also states that it integrates R&D, production, and sales, supporting a positive assessment of innovation capability.
Production capacityThe supplier operates a 54,736.0 m² manufacturing plant, has 559 employees, and covers pharmaceutical, API, medical-device, medical-supply, textile, and protective-product production activities. Valid manufacturing contracts exist with each related subcontractor, although the supplier reports no in-stock service capacity.
Customization capabilityOEM service for well-known brands is explicitly confirmed, indicating the ability to manufacture according to customer or brand requirements. The supplier also has documented service-capability assessment procedures and 30 qualified service suppliers, but no further details on product-development customization scope are provided.

Product Q&A

Q:What are the main indications for this Sodium Chloride Injection?
A:
It is used for treating dehydration (hypotonic, isotonic, hypertonic), hypertonic nonketotic diabetic coma, low chlorine metabolic alkalosis, rinsing eyes, washing wounds, and inducing abortion.
Q:What is the shelf life of the product?
A:
The validity period is 24 months when stored in sealed conditions.
Q:Does the manufacturer offer customization services?
A:
Yes, we offer full customization, minor customization, and flexible customization based on samples or designs.
Q:What are the packaging specifications?
A:
The product is packaged in a 250mL polypropylene infusion bottle containing 2.25g of Sodium Chloride.
Q:What is the production capacity and lead time?
A:
We have 12 production lines. Lead time is within 15 workdays off-peak and one month during peak season.

Send Inquiry

*To:Huaren Pharmaceutical Co., Ltd.Huaren Pharmaceutical Co., Ltd.
*Content:
0/4000

Supplier replies will be sent to your registered email

You may also like

High Quality Food Grade Citric Acid Monohydrate
Made-in-China.com